In the present study, KRT18 was over-expressed in breast invasive carcinoma (BRCA) (Table 1), further supporting that KRT18 could represent a candidate biomarker in breast cancer for predicting poor prognosis in breast cancer. This evidence concerns the gene KRT18 and invasive breast carcinoma.